STRAINCHEM enters the semi-industrial phase with France Relance.
Carbios receives support from the European Commission through the LIFE program.
Valbiotis: preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.
Pascal Mayer receives the prestigious breakthrough prize for his massive parallel sequencing technology codecovery.
Valbiotis obtains patent for its active substance TOTUM-63 in China.
Carbios and Michelin on their way to 100% sustainable tires.
With its extension project supported by France Relance, the Icare group strengthens its development ambitions.
Discover BIOLIFE ENTERPRISES special Biopôle Clermont-Limagne